Cited by 80Genetics and Neurodevelopmental DisordersGenomics and Rare DiseasesGenomic variations and chromosomal abnormalities

Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies.

Open access
Fountain, Michael D., Oleson, David S., Rech, Megan E., Segebrecht, Lara, Hunter, Jill V., McCarthy, John M., Lupo, Philip J., Holtgrewe, Manuel +48 more·2019·Genetics in Medicine

Abstract

PURPOSE: Haploinsufficiency of USP7, located at chromosome 16p13.2, has recently been reported in seven individuals with neurodevelopmental phenotypes, including developmental delay/intellectual disability (DD/ID), autism spectrum disorder (ASD), seizures, and hypogonadism. Further, USP7 was identified to critically incorporate into the MAGEL2-USP7-TRIM27 (MUST), such that pathogenic variants in USP7 lead to altered endosomal F-actin polymerization and dysregulated protein recycling. METHODS: We report 16 newly identified individuals with heterozygous USP7 variants, identified by genome or exome sequencing or by chromosome microarray analysis. Clinical features were evaluated by review of medical records. Additional clinical information was obtained on the seven previously reported individuals to fully elucidate the phenotypic expression associated with USP7 haploinsufficiency. RESULTS: The clinical manifestations of these 23 individuals suggest a syndrome characterized by DD/ID, hypotonia, eye anomalies,feeding difficulties, GERD, behavioral anomalies, and ASD, and more specific phenotypes of speech delays including a nonverbal phenotype and abnormal brain magnetic resonance image findings including white matter changes based on neuroradiologic examination. CONCLUSION: The consistency of clinical features among all individuals presented regardless of de novo USP7 variant type supports haploinsufficiency as a mechanism for pathogenesis and refines the clinical impact faced by affected individuals and caregivers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41436-019-0433-1

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • No human individuals have been identified who are USP7 homozygous-null.

    “no human individuals have been identified who are USP7 homozygous-null (Fountain et al., 2019)”

    From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Fountain et al., 2019

  • Heterozygous loss-of-function USP7 mutations have been identified in 23 individuals, all of whom have neurodevelopmental disorders and physical characteristics including dysmorphic facial features.

    “Heterozygous loss-of-function USP7 mutations have, however, been identified in 23 individuals, all of whom have experienced neurodevelopmental disorders – characterized by developmental delay/intellectual disability (DD/ID), speech delay, behavioral anomalies and autism spectrum disorder – as well as physical characteristics that include dysmorphic facial features (Hao et al., 2015; Fountain et al”

    From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Fountain et al., 2019

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fountain, M. D., Oleson, D. S., Rech, M. E., Segebrecht, L., Hunter, J. V., McCarthy, J. M., Lupo, P. J., Holtgrewe, M., Moran, R., Rosenfeld, J. A., Isidor, B., Le Caignec, C., Saenz, M. S., Pedersen, R. C., Morgan, T. M., Pfotenhauer, J. P., Xia, F., Bi, W., Kang, S.-H. L., Patel, A., Krantz, I. D., Raible, S. E., Smith, W., Cristian, I., Torti, E., Juusola, J., Millan, F., Wentzensen, I. M., Person, R. E., Küry, S., Bézieau, S., Uguen, K., Férec, C., Munnich, A., van Haelst, M., Lichtenbelt, K. D., van Gassen, K., Hagelstrom, T., Chawla, A., Perry, D. L., Taft, R. J., Jones, M., Masser-Frye, D., Dyment, D., Venkateswaran, S., Li, C., Escobar, L. F., Horn, D., Spillmann, R. C., Peña, L., Wierzba, J., Strom, T. M., Parenti, I., Kaiser, F. J., Ehmke, N., & Schaaf, C. P.
Affiliations
  • Baylor College of Medicine (US)
  • Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
  • Texas Children's Hospital (US)
  • Cleveland Clinic (US)
  • Centre National de la Recherche Scientifique (FR)
  • Children's Hospital Colorado (US)
  • Tripler Army Medical Center (US)
  • Vanderbilt University (US)
  • University of California, Los Angeles (US)
  • Baylor Genetics (US)
  • Children's Hospital of Philadelphia (US)
  • Maine Medical Center (US)
  • Arnold Palmer Hospital for Children (US)
  • Inserm (FR)
  • University Medical Center Utrecht (NL)
  • Illumina (United States) (US)
  • University of California San Diego (US)
  • University of Ottawa (CA)
  • McMaster University (CA)
  • St Vincent Hospital (US)
  • Charité – Universitätsmedizin Berlin (DE)
  • Duke University (US)
  • Cincinnati Children's Hospital Medical Center (US)
  • Gdańsk Medical University (PL)
  • Helmholtz Munich (DE)
  • University of Lübeck (DE)
  • University of Cologne (DE)
Corresponding author
Schaaf, Christian P.
Venue
Genetics in Medicine
Publisher
Elsevier BV
Published
2019-08
Volume
21
Issue
8
Pages
1797-1807
ISSN
1098-3600 (ISSN-L)
OpenAlex
W2914144747
Cited by
80
References
27
Citations by year
2026: 15 · 2025: 18 · 2024: 9 · 2023: 5 · 2022: 17 · 2021: 5 · 2020: 9 · 2019: 2
FWCI
4.96
Type
journal article
Language
en
Open access
Locations
  • Genetics in Medicine (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by-nc-sa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by-nc-sa)
  • mediaTUM (Technical University of Munich) (submittedVersion, other-oa)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • Site cant be reached (submittedVersion, cc-by-nc-sa)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • Bundesministerium für Bildung und Forschung (01GM1520C)
  • Universität zu Lübeck
  • National Institutes of Health
  • Intellectual and Developmental Disabilities Research Center (1 U54 HD083092)
  • National Human Genome Research Institute (U01HG007942, U01HG007672)
  • NIH Office of the Director (U01HG007672, U01HG007942)
  • Office of Strategic Coordination (U01HG007942, U01HG007672)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083092)
  • Common Fund (U01HG007672, U01HG007942)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
USP7, haploinsufficiency, neurodevelopmental disorders, developmental delay, intellectual disability, autism spectrum disorder, speech delay, hypotonia, ocular abnormalities, feeding difficulties, GERD, white matter abnormalities, de novo mutations, protein recycling
MeSH terms
Problem Behavior, Autism Spectrum Disorder, Tripartite Motif Proteins, Exome Sequencing, Adolescent, Child, Child, Preschool, Chromosome Deletion, DNA-Binding Proteins, Humans, Infant, Infant, Newborn, Language Development Disorders, Intellectual Disability, Nuclear Proteins, Phenotype, Proteins, Genome, Human, Intracellular Signaling Peptides and Proteins, Haploinsufficiency, Intrinsically Disordered Proteins, Neurodevelopmental Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review